Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

58.78 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 964
Open 58.78
Bid (Size) 58.75 (1)
Ask (Size) 59.00 (1)
Prev. Close 58.78
Today's Range 58.78 - 58.78
52wk Range 58.33 - 81.44
Shares Outstanding 2,222,113,553
Dividend Yield 3.33%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bristol Myers Squibb Announces Dividend
From Bristol Myers Squibb
Via Business Wire
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
Friday, the FDA approved GSK plc's (NYSE: GSK) Ojjaara (momelotinib) for intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythemia vera and... 
Via Benzinga
Exposures Product Safety

Performance

YTD
-18.65%
-18.65%
1 Month
-5.06%
-5.06%
3 Month
-10.26%
-10.26%
6 Month
-12.58%
-12.58%
1 Year
-15.70%
-15.70%

More News

Read More
Looking Into Bristol-Myers Squibb's Recent Short Interest
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Undervalued Dividend Stocks to Buy Now
Via The Motley Fool
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
Via InvestorPlace
Bristol-Myers Squibb Plans To Double Clinical Pipeline Platforms To Support Long-Term Sustainable Growth
Via Benzinga
Bristol Myers Squibb Highlights Advancing Pipeline and Differentiated Research Platforms to Support Long-Term Sustainable Growth at R&D Day
From Bristol Myers Squibb
Via Business Wire
The Next Walgreens CEO? My Top 3 Picks to Replace Roz Brewer.
Via InvestorPlace
Recent Pullback Buying Opportunity For Blood Cancer Firm Geron: Goldman Sachs
Via Benzinga
Bristol Myers Squibb's Opdivo Plus Yervoy Combo Shows Durable, Long-Term Survival In Lung Cancer Patients
Via Benzinga
How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug
Via Benzinga
Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb’s Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 Study
From Bristol Myers Squibb
Via Business Wire
The 3 Best Pharma Stocks to Buy Now: September 2023
Via InvestorPlace
Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
Bristol Myers Squibb Celebrates a Decade of Its Coast 2 Coast 4 Cancer Cross-Country Bike Ride in Support of the V Foundation for Cancer Research
From Bristol Myers Squibb
Via Business Wire
How To Earn $500 From Pfizer Stock With Shares Trading At 52-Week Low
Via Benzinga
Topics Economy
Exposures Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
Via Benzinga
3 No-Brainer Dividend Stocks to Buy in September
Via The Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
Via The Motley Fool
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
Via MarketBeat
Topics Economy
Exposures Interest Rates
Bristol Myers Squibb to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Bristol Myers Squibb
Via Business Wire
3 Undervalued Healthcare Stocks In 2023
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.